These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19801789

  • 21. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
    Palomo IG, Mujica VE, Alarcón ML, Pereira JG, Vásquez MR.
    J Diabetes Complications; 2005 Jun; 19(3):133-7. PubMed ID: 15866057
    [Abstract] [Full Text] [Related]

  • 23. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I, Jouen F, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical consequences of antiphospholipid antibodies.
    Derksen RH, de Groot PG.
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.
    Pardo A, González-Porque P, Gobernado JM, Jiménez-Escrig A, Lousa M.
    Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis.
    Juanola X, Mateo L, Domenech P, Bas J, Contreras N, Nolla JM, Roig-Escofet D.
    J Rheumatol; 1995 Oct; 22(10):1891-3. PubMed ID: 8991987
    [Abstract] [Full Text] [Related]

  • 30. Antiphospholipid (aPL) antibodies in end-stage renal disease.
    Fabrizi F, Sangiorgio R, Pontoriero G, Corti M, Tentori F, Troina E, Locatelli F.
    J Nephrol; 1999 Oct; 12(2):89-94. PubMed ID: 10378664
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
    van Goor MP, Alblas CL, Leebeek FW, Koudstaal PJ, Dippel DW.
    Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.